Structural Basis of Chemokine Sequestration by CrmD, a Poxvirus-Encoded Tumor Necrosis Factor Receptor

English version České info

Pathogens have evolved sophisticated mechanisms to evade detection and destruction by the host immune system. Large DNA viruses encode homologues of chemokines and their receptors, as well as chemokine-binding proteins (CKBPs) to modulate the chemokine network in host response. The SECRET domain (smallpox virus-encoded chemokine receptor) represents a new family of viral CKBPs that binds a subset of chemokines from different classes to inhibit their activities, either independently or fused with viral tumor necrosis factor receptors (vTNFRs). Here we present the crystal structures of the SECRET domain of vTNFR CrmD encoded by ectromelia virus and its complex with chemokine CX3CL1. The SECRET domain adopts a β-sandwich fold and utilizes its β-sheet I surface to interact with CX3CL1, representing a new chemokine-binding manner of viral CKBPs. Structure-based mutagenesis and biochemical analysis identified important basic residues in the 40s loop of CX3CL1 for the interaction. Mutation of corresponding acidic residues in the SECRET domain also affected the binding for other chemokines, indicating that the SECRET domain binds different chemokines in a similar manner. We further showed that heparin inhibited the binding of CX3CL1 by the SECRET domain and the SECRET domain inhibited RAW264.7 cell migration induced by CX3CL1. These results together shed light on the structural basis for the SECRET domain to inhibit chemokine activities by interfering with both chemokine-GAG and chemokine-receptor interactions.

Vyšlo v časopise: Structural Basis of Chemokine Sequestration by CrmD, a Poxvirus-Encoded Tumor Necrosis Factor Receptor. PLoS Pathog 7(7): e32767. doi:10.1371/journal.ppat.1002162
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002162

Souhrn

Zdroje

1. BaggioliniM 1998 Chemokines and leukocyte traffic. Nature 392 565 568

2. RossiDZlotnikA 2000 The biology of chemokines and their receptors. Annu Rev Immunol 18 217 242

3. RotAvon AndrianUH 2004 Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22 891 928

4. CharoIFRansohoffRM 2006 The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 610 621

5. RollinsBJ 1997 Chemokines. Blood 90 909 928

6. AllenSJCrownSEHandelTM 2007 Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25 787 820

7. HamelDJSielaffIProudfootAEHandelTM 2009 Chapter 4. Interactions of chemokines with glycosaminoglycans. Methods Enzymol 461 71 102

8. Lortat-JacobHGrosdidierAImbertyA 2002 Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci U S A 99 1229 1234

9. SeetBTJohnstonJBBrunettiCRBarrettJWEverettH 2003 Poxviruses and immune evasion. Annu Rev Immunol 21 377 423

10. AlcamiA 2003 Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3 36 50

11. MantovaniABonecchiRLocatiM 2006 Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6 907 918

12. GrahamKALalaniASMacenJLNessTLBarryM 1997 The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229 12 24

13. SmithCASmithTDSmolakPJFriendDHagenH 1997 Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236 316 327

14. AlcamiASymonsJACollinsPDWilliamsTJSmithGL 1998 Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 160 624 633

15. LalaniASNessTLSinghRHarrisonJKSeetBT 1998 Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology 250 173 184

16. BurnsJMDairaghiDJDeitzMTsangMSchallTJ 2002 Comprehensive mapping of poxvirus vCCI chemokine-binding protein. Expanded range of ligand interactions and unusual dissociation kinetics. J Biol Chem 277 2785 2789

17. BaharMWKenyonJCPutzMMAbresciaNGPeaseJE 2008 Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog 4 e5

18. Ruiz-ArguelloMBSmithVPCampanellaGSBaleuxFArenzana-SeisdedosF 2008 An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J Virol 82 917 926

19. ParryCMSimasJPSmithVPStewartCAMinsonAC 2000 A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191 573 578

20. van BerkelVBarrettJTiffanyHLFremontDHMurphyPM 2000 Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol 74 6741 6747

21. AlexanderJMNelsonCAvan BerkelVLauEKStudtsJM 2002 Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111 343 356

22. WebbLMSmithVPAlcamiA 2004 The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans. Faseb J 18 571 573

23. Alexander-BrettJMFremontDH 2007 Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor. J Exp Med 204 3157 3172

24. LalaniASGrahamKMossmanKRajarathnamKClark-LewisI 1997 The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol 71 4356 4363

25. SeetBTMcCaughanCAHandelTMMercerABrunettiC 2003 Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc Natl Acad Sci U S A 100 15137 15142

26. WangDBresnahanWShenkT 2004 Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc Natl Acad Sci U S A 101 16642 16647

27. BryantNADavis-PoynterNVanderplasschenAAlcamiA 2003 Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. Embo J 22 833 846

28. JohnstonJBMcFaddenG 2004 Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes. Cell Microbiol 6 695 705

29. GrahamSCBaharMWAbresciaNGSmithGLStuartDI 2007 Structure of CrmE, a virus-encoded tumour necrosis factor receptor. J Mol Biol 372 660 671

30. AlejoARuiz-ArguelloMBHoYSmithVPSaraivaM 2006 A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc Natl Acad Sci U S A 103 5995 6000

31. AlcamiASaraivaM 2009 Chemokine binding proteins encoded by pathogens. Adv Exp Med Biol 666 167 179

32. AntonetsDVNepomnyashchikhTSShchelkunovSN 2010 SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family. BMC research notes 3 271

33. AnXLiuFFangMZhuYWangH 2003 Isolation and identification of a mouse poxvirus and its infectivity. Virologica Sinica 18 563 565

34. CarfiASmithCASmolakPJMcGrewJWileyDC 1999 Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc Natl Acad Sci U S A 96 12379 12383

35. ArnoldPLFremontDH 2006 Structural determinants of chemokine binding by an Ectromelia virus-encoded decoy receptor. J Virol 80 7439 7449

36. ZhangLDeriderMMcCornackMAJaoSCIsernN 2006 Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta. Proc Natl Acad Sci U S A 103 13985 13990

37. SeetBTSinghRPaavolaCLauEKHandelTM 2001 Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc Natl Acad Sci U S A 98 9008 9013

38. BeckCGStuderCZuberJFDemangeBJManningU 2001 The viral CC chemokine-binding protein vCCI inhibits monocyte chemoattractant protein-1 activity by masking its CCR2B-binding site. J Biol Chem 276 43270 43276

39. FrauenschuhAPowerCADeruazMFerreiraBRSilvaJS 2007 Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus. J Biol Chem 282 27250 27258

40. DeruazMFrauenschuhAAlessandriALDiasJMCoelhoFM 2008 Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J Exp Med 205 2019 2031

41. SmithPFallonREManganNEWalshCMSaraivaM 2005 Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J Exp Med 202 1319 1325

42. DiasJMLosbergerCDeruazMPowerCAProudfootAE 2009 Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3. PLoS One 4 e8514

43. GevreyJCIsaacBMCoxD 2005 Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine). J Immunol 175 3737 3745

44. HandelTMJohnsonZCrownSELauEKProudfootAE 2005 Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. Annu Rev Biochem 74 385 410

45. ProudfootAE 2006 The biological relevance of chemokine-proteoglycan interactions. Biochem Soc Trans 34 422 426

46. ShawJPJohnsonZBorlatFZwahlenCKunglA 2004 The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. Structure 12 2081 2093

47. MurphyJWChoYSachpatzidisAFanCHodsdonME 2007 Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem 282 10018 10027

48. CrumpMPGongJHLoetscherPRajarathnamKAmaraA 1997 Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. Embo J 16 6996 7007

49. PakianathanDRKutaEGArtisDRSkeltonNJHebertCA 1997 Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. Biochemistry 36 9642 9648

50. BondueAJaoSCBlanpainCParmentierMLiWangPJ 2002 Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding. Biochemistry 41 13548 13555

51. FernandezEJLolisE 2002 Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42 469 499

52. OtwinowskiZBorekDMajewskiWMinorW 2003 Multiparametric scaling of diffraction intensities. Acta Crystallogr A 59 228 234

53. SchneiderTRSheldrickGM 2002 Substructure solution with SHELXD. Acta Crystallogr D Biol Crystallogr 58 1772 1779

54. SheldrickGM 2002 Macromolecular phasing with SHELXE. Z Kristallogr 217 644 650

55. PapeTSchneiderTR 2004 HKL2MAP, a graphical user interface for phasing with SHELX programs. J Appl Crystallogr 37 843 844

56. The CCP4 suite: programs for protein crystallography 1994 Acta Crystallogr D Biol Crystallogr 50 760 763

57. LangerGCohenSXLamzinVSPerrakisA 2008 Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc 3 1171 1179

58. EmsleyPCowtanK 2004 Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60 2126 2132

59. AdamsPDGrosse-KunstleveRWHungLWIoergerTRMcCoyAJ 2002 PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58 1948 1954

60. McCoyAJGrosse-KunstleveRWAdamsPDWinnMDStoroniLC 2007 Phaser crystallographic software. J Appl Crystallogr 40 658 674